¼¼°èÀÇ ÇコÄÉ¾î ºñµð¿À ȸÀÇ ¼Ö·ç¼Ç ½ÃÀå
Healthcare Video Conferencing Solutions
»óǰÄÚµå : 1774898
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 474 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,239,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,719,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°è ÇコÄÉ¾î ºñµð¿À ȸÀÇ ¼Ö·ç¼Ç ½ÃÀåÀº 2030³â±îÁö 1,183¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 906¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ÇコÄÉ¾î ºñµð¿À ȸÀÇ ¼Ö·ç¼Ç ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 4.6%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 1,183¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ Çϵå¿þ¾î ÄÄÆ÷³ÍÆ®´Â CAGR 4.3%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 654¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¼ÒÇÁÆ®¿þ¾î ÄÄÆ÷³ÍÆ® ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 5.2%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 247¾ï ´Þ·¯, Áß±¹Àº CAGR 8.2%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹Ãø

¹Ì±¹ÀÇ ÇコÄÉ¾î ºñµð¿À ȸÀÇ ¼Ö·ç¼Ç ½ÃÀåÀº 2024³â¿¡ 247¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 244¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 8.2%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î¼­´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 1.9%¿Í 3.5%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.7%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

¼¼°è ÇコÄɾî È­»óȸÀÇ ¼Ö·ç¼Ç ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

È­»óȸÀÇ ¼Ö·ç¼ÇÀÌ ÇコÄɾî Ä¿¹Â´ÏÄÉÀ̼ÇÀ» º¯È­½ÃŰ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

ÀÇ·á¾÷°èÀÇ Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹æ½ÄÀº ºü¸£°Ô º¯È­Çϰí ÀÖÀ¸¸ç, È­»óȸÀÇ ¼Ö·ç¼ÇÀº ¿ø°Ý Áø·á, °øµ¿ ÀÇ»ç°áÁ¤, ÀÇ·á ±³À°¿¡ ÇʼöÀûÀÎ µµ±¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. È®Àå °¡´ÉÇÑ °¡»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç Ç÷§ÆûÀÇ Çʿ伺ÀÌ °­Á¶µÇ°í ÀÖ½À´Ï´Ù. ¿ø°Ý ÀÇ·á´Â ÀÇ·á ¼­ºñ½º Á¦°ø ¹æ½ÄÀÇ ÁÖ·ù°¡ µÇ¾î Àǻ簡 ¿ø°ÝÀ¸·Î ȯÀÚ¿Í »ó´ãÇÒ ¼ö ÀÖ°Ô ÇÔÀ¸·Î½á º´¿ø ¹æ¹®À» ÁÙÀ̰í, ³óÃÌ Áö¿ª°ú ÀÇ·á ¼­ºñ½º°¡ ºÎÁ·ÇÑ Áö¿ª ÁÖ¹ÎÀÇ Á¢±Ù¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á ¼­ºñ½º Á¦°ø¾÷üµéÀº È­»óȸÀǸ¦ ÅëÇØ ´ÙÇÐÁ¦ ÆÀ °£ÀÇ Çù¾÷À» °­È­Çϰí, Àü¹®°¡µéÀÌ Áö¸®Àû Á¦¾à ¾øÀÌ º¹ÀâÇÑ »ç·Ê¿¡ ´ëÇØ ³íÀÇÇÏ°í ¼¼ÄÁµå ¿ÀÇǴϾðÀ» Á¦°øÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. º´¿ø°ú ÀÇ·á±â°üÀº °¡»ó ±³À° ÇÁ·Î±×·¥, CME(Continuing Medical Education), Àü¹®°¡ °£ ½Ç½Ã°£ Áö½Ä °øÀ¯¸¦ À§ÇØ ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀ» Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù. Á¦¾àȸ»ç¿Í ÀÇ·á ¿¬±¸±â°üÀº ¿ø°Ý ÀÓ»ó½ÃÇè¿¡ È­»óȸÀǸ¦ ÅëÇÕÇÏ¿© ¹°·ù ¹®Á¦¸¦ ÁÙÀ̰í ȯÀÚ Âü¿©À²À» ³ôÀ̰í ÀÖ½À´Ï´Ù. À¯¿¬ÇÏ°í ºñ¿ë È¿À²ÀûÀÎ ÇコÄɾî Ä¿¹Â´ÏÄÉÀÌ¼Ç ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áö¼ÓÀûÀ¸·Î Áõ°¡ÇÔ¿¡ µû¶ó È­»óȸÀÇ Ç÷§ÆûÀº Çö´ë ÀÇ·á ÀÎÇÁ¶ó¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ¾Æ È¿À²¼º°ú ¿¬°á¼ºÀ» ³ôÀ̰í ȯÀÚ Ä¡·á °á°ú¸¦ °³¼±Çϰí ÀÖ½À´Ï´Ù.

AI, Ŭ¶ó¿ìµå ÄÄÇ»ÆÃ, 5G°¡ ÇコÄÉ¾î ºÐ¾ßÀÇ È­»óȸÀǸ¦ ¾î¶»°Ô °­È­ÇÒ °ÍÀΰ¡?

ÀΰøÁö´É(AI), Ŭ¶ó¿ìµå ÄÄÇ»ÆÃ, 5G ±â¼úÀÇ ÅëÇÕÀº ÇコÄɾî È­»óȸÀÇ ¼Ö·ç¼ÇÀÇ È¿À²¼º°ú ¿ª·®À» Å©°Ô Çâ»ó½Ã۰í ÀÖÀ¸¸ç, AI ±â¹Ý °¡»ó ºñ¼­ ¹× À½¼º ÀÎ½Ä µµ±¸´Â ÀÚµ¿ ³ìÃë, ½Ç½Ã°£ ¹ø¿ª, Áö´ÉÇü ½ºÄÉÁÙ¸µ, ÀÚµ¿ ³ìÀ½, ½Ç½Ã°£ ¹ø¿ª ¹× ½ºÄÉÁÙ °ü¸®¸¦ °¡´ÉÇÏ°Ô ÇÏ¿© ÀÇ·á Àü¹®°¡µéÀÇ ¿öÅ©ÇÃ·Î¿ì °ü¸®¸¦ °³¼±Çϰí ÀÖ½À´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý È­»óȸÀÇ Ç÷§ÆûÀº ¾ÈÀüÇϰí È®Àå °¡´ÉÇÑ ¼Ö·ç¼ÇÀ» Á¦°øÇÏ¿© ´ë±Ô¸ð On-Premise ÀÎÇÁ¶ó°¡ ÇÊ¿ä ¾øÀÌ °¡»ó Áø·á¿¡ ¿øÈ°ÇÏ°Ô Á¢±ÙÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù. °í±Þ ¾Ïȣȭ ¹× AI ±â¹Ý »çÀ̹ö º¸¾È µµ±¸´Â HIPAA ¹× GDPR(EU °³ÀÎÁ¤º¸º¸È£±ÔÁ¤)°ú °°Àº ÀÇ·á ±ÔÁ¦¸¦ ÁؼöÇÏ°í °¡»ó ´ëÈ­ Áß È¯ÀÚÀÇ ±â¹ÐÀ» º¸È£Çϸç, 5G ±â¼úÀÇ µµÀÔÀ¸·Î È­»ó ÅëÈ­ ǰÁúÀÌ È¹±âÀûÀ¸·Î °³¼±µÇ°í Áö¿¬ ½Ã°£ÀÌ ´ÜÃàµÇ¸ç, °íÇØ»óµµ ½ºÆ®¸®¹ÖÀÌ °¡´ÉÇØÁ® ¿ø°ÝÁö¿¡¼­µµ ¿ø°ÝÁö¿¡¼­µµ ¾ÈÁ¤ÀûÀÎ ¿¬°á¼ºÀÌ º¸ÀåµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Áõ°­Çö½Ç(AR)°ú °¡»óÇö½Ç(VR)Àº ¸ôÀÔÇü ÀÇ·á ±³À° ¹× ¿ø°Ý ¼ö¼ú Áö¿øÀ» À§ÇØ È­»óȸÀÇ Ç÷§Æû¿¡ ÅëÇյǰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀÇ ¹ßÀüÀ¸·Î ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü´Â º¸´Ù °³ÀÎÈ­µÈ µ¥ÀÌÅÍ ±â¹Ý °¡»ó »ó´ãÀ» Á¦°øÇÒ ¼ö ÀÖ°Ô µÇ¾î ÀÇ·á ¼­ºñ½ºÀÇ ¹üÀ§¿Í Á¢±Ù¼ºÀ» Àü ¼¼°è·Î È®´ëÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

ÇコÄɾî È­»óȸÀÇ µµÀÔÀÇ ÁÖ¿ä °úÁ¦´Â?

ÇコÄɾî È­»óȸÀÇ ¼Ö·ç¼ÇÀÇ ÀåÁ¡¿¡µµ ºÒ±¸Çϰí, ±× µµÀÔ°ú º¸±Þ¿¡´Â ¸î °¡Áö °úÁ¦°¡ ³²¾ÆÀÖ½À´Ï´Ù. ÁÖ¿ä °ü½É»ç Áß Çϳª´Â µ¥ÀÌÅÍ º¸¾È°ú ÇÁ¶óÀ̹ö½ÃÀÔ´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü´Â µ¥ÀÌÅÍ À¯Ãâ ¹× ¹«´Ü ¾×¼¼½º¸¦ ¹æÁöÇϱâ À§ÇØ È­»óȸÀÇ Ç÷§ÆûÀÌ ¹Ì±¹ÀÇ HIPAA ¹× À¯·´ÀÇ GDPR(EU °³ÀÎÁ¤º¸º¸È£±ÔÁ¤)°ú °°Àº ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©¸¦ ÁؼöÇÏ´ÂÁö È®ÀÎÇØ¾ß ÇÕ´Ï´Ù. ¶ÇÇÑ, ¸ðµç ȯÀÚ¿Í ÀÇ·á½Ã¼³ÀÌ ¿øÈ°ÇÑ È­»óȸÀÇ¿¡ ÇÊ¿äÇÑ °í¼Ó ÀÎÅͳݰú ÷´Ü µðÁöÅÐ Àåºñ¸¦ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â °ÍÀº ¾Æ´Ï±â ¶§¹®¿¡ µðÁöÅÐ °ÝÂ÷(Á¤º¸ °ÝÂ÷)µµ Å« ¹®Á¦ÀÔ´Ï´Ù. ¶ÇÇÑ, ÀüÀÚÀǹ«±â·Ï(EHR), º´¿ø °ü¸® ½Ã½ºÅÛ µî ±âÁ¸ ÇコÄɾî IT ÀÎÇÁ¶ó¿ÍÀÇ ÅëÇÕÀº º¹ÀâÇϸç, ¸ÂÃãÇü ¼Ö·ç¼Ç°ú »óÈ£¿î¿ë¼º Ç¥ÁØÀÌ ÇÊ¿äÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀϺΠÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿Í ȯÀÚ, ƯÈ÷ ÀüÅëÀûÀÎ Áø·á ¸ðµ¨ÀÌ »Ñ¸® ±í°Ô ÀÚ¸® ÀâÀº Áö¿ª¿¡¼­´Â µðÁöÅÐ ÇコÄÉ¾î µµÀÔ¿¡ ´ëÇÑ °ÅºÎ°¨µµ È­»óȸÀÇÀÇ º¸±ÞÀ» °¡·Î¸·´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±¹°¡¸¶´Ù °¡»ó Áø·á¿¡ ´ëÇÑ »óȯ Á¤Ã¥ÀÌ ´Ù¸£±â ¶§¹®¿¡ ÀÇ·á±â°üÀÇ ¿ø°Ý ÀÇ·á ¼­ºñ½ºÀÇ ÀçÁ¤Àû ½ÇÇà °¡´É¼º¿¡µµ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇϱâ À§Çؼ­´Â ÁøÈ­ÇÏ´Â ÇコÄÉ¾î ¿ä±¸»çÇ×°ú ±ÔÁ¦ ¿ä°ÇÀ» ÃæÁ·ÇÏ´Â ¾ÈÀüÇÏ°í »óÈ£¿î¿ë¼ºÀÌ ¶Ù¾î³ª¸ç »ç¿ëÇϱ⠽¬¿î È­»óȸÀÇ ¼Ö·ç¼Ç¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ÅõÀÚ°¡ ÇÊ¿äÇÕ´Ï´Ù.

ÇコÄɾî È­»óȸ ½ÃÀåÀÇ ¼ºÀåÀ» ÁÖµµÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

ÇコÄɾî È­»óȸÀÇ ¼Ö·ç¼Ç ½ÃÀåÀÇ ¼ºÀåÀº ¿ø°Ý ÀÇ·á ¼­ºñ½ºÀÇ ºÎ»ó, ±â¼ú ¹ßÀü, °¡»ó Áø·á¿¡ ´ëÇÑ È¯ÀÚ ¼ö¿ä Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¿ø°Ý ÀÇ·á ÇÁ·Î±×·¥ÀÇ ±Þ¼ÓÇÑ È®´ë´Â Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê¿Í ¿ø°Ý Áø·á¿¡ ´ëÇÑ º¸Çè Àû¿ë¿¡ ÈûÀÔ¾î ÀÇ·á ºÐ¾ß¿¡¼­ È­»ó ȸÀÇ Ç÷§ÆûÀÇ Ã¤ÅÃÀ» Å©°Ô ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¸¸¼º Áúȯ Áõ°¡¿Í °í·ÉÈ­µµ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¹× ÈÄ¼Ó Áø·á¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½ÃÄÑ º´¿øÀÇ ºÎ´ãÀ» ÁÙÀ̰í ÀÇ·á ¼­ºñ½º Á¢±Ù¼ºÀ» Çâ»ó½ÃŰ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, 5G ³×Æ®¿öÅ©¿Í AI ±â¹Ý ºñµð¿À ºÐ¼® µî µðÁöÅÐ ÀÇ·á ÀÎÇÁ¶óÀÇ È®ÀåÀ¸·Î °¡»ó Áø·áÀÇ È¿À²¼º°ú ½Å·Ú¼ºÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ´ë¸é Áø·á¸¦ °¡»ó ´ëÈ­·Î º¸¿ÏÇÏ´Â ÇÏÀ̺긮µå ÇコÄÉ¾î ¸ðµ¨¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼­ ½ÃÀå È®´ë¿¡ ´õ¿í ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. Á¦¾àȸ»ç¿Í ¿¬±¸±â°üÀº ºÐ»êÇü ÀÓ»ó½ÃÇè¿¡ È­»óȸÀǸ¦ Ȱ¿ëÇÏ¿© ´õ ¸¹Àº ȯÀÚ°¡ Âü¿©ÇÒ ¼ö ÀÖµµ·Ï Çϰí, ¿î¿µ ºñ¿ëÀ» Àý°¨Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °¡»ó Ç÷§ÆûÀ» ÅëÇÑ ÀÇ·á ±³À° ¹× ÀÎÀç À°¼º¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ È­»óȸÀÇ ¼Ö·ç¼Ç¿¡ »õ·Î¿î ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. µðÁöÅÐ ÇコÄɾ °è¼Ó ÁøÈ­ÇÏ´Â °¡¿îµ¥, ¾ÈÀüÇÏ°í °íǰÁúÀÇ AI ±â¹Ý È­»óȸÀÇ ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä´Â Áö¼ÓÀûÀ¸·Î Áõ°¡ÇÏ¿© ¿ø°Ý ÀÇ·á Á¦°ø ¹× ¼¼°è ÀÇ·á Çù·ÂÀÇ ¹Ì·¡¸¦ Çü¼ºÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºÎ¹®

ÄÄÆ÷³ÍÆ®(Çϵå¿þ¾î ÄÄÆ÷³ÍÆ®, ¼ÒÇÁÆ®¿þ¾î ÄÄÆ÷³ÍÆ®, ¼­ºñ½º ÄÄÆ÷³ÍÆ®), Àü°³(On-PremiseÀü°³, Ŭ¶ó¿ìµå ±â¹Ý Àü°³), ¿ëµµ(¿ø°ÝÀǷᣦ°¡»ó »ó´ã ¿ëµµ, ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¿ëµµ, ¿Â¶óÀÎ ÀÇ·á ±³À°£¦Æ®·¹ÀÌ´× ¿ëµµ, ±âŸ ¿ëµµ), ÃÖÁ¾ ¿ëµµ(º´¿ø£¦Å¬¸®´Ð ÃÖÁ¾ ¿ëµµ, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC) ÃÖÁ¾ ¿ëµµ, ÀÀ±ÞÀÇ·á¼¾ÅÍ ÃÖÁ¾ ¿ëµµ, ±âŸ ÃÖÁ¾ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ Å¥·¹ÀÌÆ®µÈ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Healthcare Video Conferencing Solutions Market to Reach US$118.3 Billion by 2030

The global market for Healthcare Video Conferencing Solutions estimated at US$90.6 Billion in the year 2024, is expected to reach US$118.3 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Hardware Component, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$65.4 Billion by the end of the analysis period. Growth in the Software Component segment is estimated at 5.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$24.7 Billion While China is Forecast to Grow at 8.2% CAGR

The Healthcare Video Conferencing Solutions market in the U.S. is estimated at US$24.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$24.4 Billion by the year 2030 trailing a CAGR of 8.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.9% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global Healthcare Video Conferencing Solutions Market - Key Trends & Drivers Summarized

Why Are Video Conferencing Solutions Reshaping Healthcare Communication?

The healthcare industry has witnessed a rapid transformation in communication methods, with video conferencing solutions emerging as an essential tool for remote consultations, collaborative decision-making, and medical education. The shift toward digital healthcare services, accelerated by the COVID-19 pandemic, has highlighted the need for seamless, secure, and scalable virtual communication platforms. Telemedicine has become a mainstream healthcare delivery method, allowing physicians to consult with patients remotely, reducing hospital visits, and increasing accessibility for individuals in rural or underserved areas. Additionally, healthcare providers are using video conferencing to enhance collaboration among multidisciplinary teams, enabling specialists to discuss complex cases and provide second opinions without geographical constraints. Hospitals and medical institutions are leveraging these solutions for virtual training programs, continuing medical education (CME), and real-time knowledge sharing among professionals. Pharmaceutical and medical research organizations are also integrating video conferencing for remote clinical trials, reducing logistical challenges and improving patient participation. As the demand for flexible and cost-effective healthcare communication solutions continues to grow, video conferencing platforms are becoming indispensable in modern medical infrastructure, fostering efficiency, connectivity, and better patient outcomes.

How Are AI, Cloud Computing, and 5G Enhancing Video Conferencing in Healthcare?

The integration of artificial intelligence (AI), cloud computing, and 5G technology is significantly enhancing the efficiency and capabilities of healthcare video conferencing solutions. AI-powered virtual assistants and speech recognition tools are enabling automated transcriptions, real-time translation, and intelligent scheduling, improving workflow management for healthcare professionals. Cloud-based video conferencing platforms provide secure and scalable solutions that facilitate seamless access to virtual consultations, eliminating the need for extensive on-premise infrastructure. Advanced encryption and AI-driven cybersecurity tools are ensuring compliance with healthcare regulations such as HIPAA and GDPR, protecting patient confidentiality during virtual interactions. The deployment of 5G technology has drastically improved video call quality by reducing latency, enabling high-definition streaming, and ensuring stable connectivity even in remote locations. Additionally, augmented reality (AR) and virtual reality (VR) are being integrated into video conferencing platforms for immersive medical training and remote surgery assistance. With these technological advancements, healthcare providers can deliver more personalized and data-driven virtual consultations, expanding the reach and accessibility of medical services worldwide.

What Are the Major Challenges in Healthcare Video Conferencing Adoption?

Despite the advantages of healthcare video conferencing solutions, several challenges remain in their adoption and widespread implementation. One of the primary concerns is data security and privacy, as virtual consultations involve the transmission of sensitive patient information. Healthcare providers must ensure that video conferencing platforms comply with strict regulatory frameworks, including HIPAA in the U.S. and GDPR in Europe, to prevent data breaches and unauthorized access. Another significant challenge is the digital divide, as not all patients and healthcare facilities have access to high-speed internet and advanced digital devices required for seamless video conferencing. Additionally, integration with existing healthcare IT infrastructure, such as electronic health records (EHRs) and hospital management systems, can be complex, requiring customized solutions and interoperability standards. Resistance to digital healthcare adoption among some providers and patients, particularly in regions with deeply ingrained traditional care models, also poses a barrier to widespread video conferencing adoption. Moreover, reimbursement policies for virtual consultations vary across countries, affecting the financial viability of telemedicine services for healthcare institutions. Addressing these challenges requires continued investment in secure, interoperable, and user-friendly video conferencing solutions that align with evolving healthcare needs and regulatory requirements.

What Is Driving the Growth of the Healthcare Video Conferencing Market?

The growth in the healthcare video conferencing solutions market is driven by several factors, including the rise of telehealth services, technological advancements, and increasing patient demand for virtual care. The rapid expansion of telemedicine programs, fueled by government initiatives and insurance coverage for remote consultations, has significantly boosted the adoption of video conferencing platforms in healthcare. The increasing prevalence of chronic diseases and the aging population have also contributed to the demand for remote patient monitoring and follow-up consultations, reducing the burden on hospitals and improving healthcare accessibility. Additionally, the expansion of digital health infrastructure, including 5G networks and AI-driven video analytics, is making virtual consultations more efficient and reliable. The growing preference for hybrid healthcare models, where in-person visits are supplemented with virtual interactions, is further driving market expansion. Pharmaceutical companies and research institutions are leveraging video conferencing for decentralized clinical trials, enabling broader patient participation and reducing operational costs. Furthermore, the rising focus on medical education and workforce training through virtual platforms is creating new opportunities for video conferencing solutions. As digital healthcare continues to evolve, the demand for secure, high-quality, and AI-powered video conferencing technologies is expected to witness sustained growth, shaping the future of remote healthcare delivery and global medical collaboration.

SCOPE OF STUDY:

The report analyzes the Healthcare Video Conferencing Solutions market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Hardware Component, Software Component, Services Component); Deployment (On-Premise Deployment, Cloud- Based Deployment); Application (Telemedicine & Virtual Consultations Application, Remote Patient Monitoring Application, Online Medical Education & Training Application, Other Applications); End-Use (Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use, Urgent Care Centers End-Use, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â